ITR-U Filing Now Live: Who Can File And What You Should Know
ITR-U enables eligible individuals to rectify omissions or mistakes in their earlier income tax filings by submitting an updated return under Section 139(8A) of the Income Tax Act.
Income Tax Return: The income tax department has launched the Updated Return (ITR-U) filing facility for the assessment years (AY) 2021-22 and 2022-23 for taxpayers using ITR-1 and ITR-2 forms. This enables eligible individuals to rectify omissions or mistakes in their earlier income tax filings by submitting an updated return under Section 139(8A) of the Income Tax Act.
'Kind Attention Taxpayers! The facility for filing Updated Returns for AY 2021-22 and AY 2022-23 for ITR-1 & ITR-2 is now available," the department on Wednesday said in a post on X (formerly Twitter).
What is an Updated Return (ITR-U)?
The ITR-U form was introduced in Budget 2022 to allow taxpayers a chance to voluntarily correct their return even after the expiry of the original due date, revised return, or belated return. Taxpayers can file an updated return within 24 months from the end of the relevant assessment year.
This means:
For AY 2021-22 (FY 2020-21), the updated return window closes on March 31, 2024
For AY 2022-23 (FY 2021-22), the window remains open until March 31, 2025.
However, in the 2025 Union Budget, Finance Minister Nirmala Sitharaman announced that the deadline for filing an Updated Return (ITR‑U) under Section 139(8A) will be extended from 2 years to 4 years — i.e., 48 months from the end of the relevant assessment year.
The amendment took effect from April 1, 2025, applying to returns filed in Assessment Year 2025‑26 and onward.
Who Can File ITR-U for ITR-1 and ITR-2?
ITR-1 (Sahaj) is applicable for individuals having income up to Rs 50 lakh from salary, one house property, and other sources (like interest).
ITR-2 is used by individuals and HUFs not having income from business or profession.
When Can You Not File ITR-U?
Additional Tax Payable
Filing an updated return comes with a penalty in the form of additional tax:
50% of the additional tax liability if filed within 12 months
100% if filed between 12 and 24 months
This is over and above the regular tax and interest dues.
Why It Matters
The ITR-U facility is a significant reform aimed at increasing tax compliance and transparency by giving taxpayers an opportunity to voluntarily fix errors without fear of prosecution. With the facility now enabled for ITR-1 and ITR-2 for AYs 2021-22 and 2022-23, salaried individuals and HUFs have a clear path to correct mistakes from the past.
Tax experts advise taxpayers to consult a qualified tax professional before filing ITR-U, especially since it involves additional tax and may require proper calculation and documentation to avoid notices.
For filing, taxpayers can log in to the Income Tax e-filing portal and select the updated return option under their respective assessment year. The forms for ITR-1 and ITR-2 have now been updated to accommodate ITR-U filing.
tags :
income tax ITR filing
view comments
Location :
New Delhi, India, India
First Published:
July 31, 2025, 12:37 IST
News business » tax ITR-U Filing Now Live: Who Can File And What You Should Know
Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
42 minutes ago
- India Today
Worried about ethanol-blended petrol? Government says it's safe for your vehicles
Amid growing concerns over the impact of 20% ethanol-blended petrol (E20) on vehicle performance, the Ministry of Petroleum and Natural Gas has issued a detailed clarification dismissing such fears as 'largely unfounded and not supported by scientific evidence or expert analysis.'In a post on X (formerly Twitter), the ministry responded to recent media reports questioning whether E20 fuel could damage older vehicles or degrade the driving multiple studies and expert assessments, it stated that E20 is both safe and beneficial. According to the ministry, long-term testing of both carbureted and fuel-injected vehicles across 100,000 km showed 'no statistically significant differences' in power, torque, or fuel efficiency between E20 and conventional petrol. These tests were carried out every 10,000 km and evaluated not only engine performance but also emissions and mechanical assessments by the Automotive Research Association of India (ARAI), Indian Institute of Petroleum (IIP), and Indian Oil Corporation's R&D wing confirmed that even older vehicles—or 'legacy vehicles'—did not suffer from abnormal wear and tear. E20 also passed hot and cold engine start tests without any sign of engine MINOR DROP IN FUEL EFFICIENCYOne of the most frequently raised concerns around E20 is reduced mileage. Ethanol has a lower energy density than petrol, which does result in a minor drop in fuel economy. The ministry acknowledged this but clarified that the reduction is limited to around 1–2% for vehicles designed for E10 and calibrated for E20. In older or non-optimised vehicles, it could range from 3–6%.However, this drop is far from 'drastic,' the ministry noted, and can be mitigated with proper engine tuning and the use of E20-compatible materials—measures that leading automakers have already adopted since April 2023, according to the Society of Indian Automobile Manufacturers (SIAM).Concerns about E20 causing corrosion in vehicle components were also dismissed. The ministry explained that corrosion inhibitors are already part of the fuel's formulation, and safety specifications are clearly defined under BIS and Automotive Industry Standards. In older vehicles, some rubber components or gaskets may need replacement after 20,000 to 30,000 km—an inexpensive and routine maintenance BENEFITThe government reiterated that ethanol blending isn't just safe—it's also environmentally sustainable and economically strategic. Ethanol, being a biofuel, replaces fossil-based petrol and significantly cuts down CO2 emissions. A Niti Aayog study found that lifecycle emissions from sugarcane-based ethanol are 65% lower than petrol, while maize-based ethanol emits 50% less greenhouse is now being produced from diverse feedstocks including surplus rice, maize, damaged grains, and agri-residues, aligning with India's push for second-generation (2G) biofuels. This not only reduces environmental impact but also strengthens rural 2014-15, India has saved over Rs 1.40 lakh crore in foreign exchange by substituting petrol with ethanol. At the same time, the ethanol procurement programme has facilitated prompt payments of over Rs 1.20 lakh crore to farmers, generating jobs and demand in rural with its higher octane rating (~108.5 compared to petrol's 84.4), also supports the performance needs of modern high-compression engines. Ethanol's higher heat of vaporisation lowers the intake manifold temperature, improving engine efficiency and contributing to better ride TRANSITIONAddressing claims that the shift to E20 has been sudden or poorly communicated, the ministry pointed to the Roadmap for Ethanol Blending in India 2020–25, publicly available since 2021. The implementation has followed a phased, multi-stakeholder approach involving coordination with automakers, fuel companies, and regulatory ministry made it clear: narratives suggesting that ethanol-blended petrol harms vehicles or short-changes consumers 'lack technical foundation.' Backed by research, standards, and a national roadmap, E20 is being positioned as a scientifically sound, environmentally responsible, and economically beneficial step toward energy independence. - Ends
Economic Times
2 hours ago
- Economic Times
How to file ITR-2 for AY 2025-26 with salary, capital gains, foreign income and others; Here's a step-by-step guide
ET Online Step-by-step guide on how to file ITR-2 for AY 2025-26 with salary, capital gains, foreign income and others online and with excel utility Taxpayers who earn income from salary, capital gains, or have invested in unlisted equity shares, need to file their Income Tax Return using the ITR-2 form. For the Assessment Year 2025-26 (FY 2024-25), there are six significant updates in the ITR-2 excel utility. Some of these updates relate to reporting of capital losses on share buyback, bifurcation of acquisition and improvement costs for real estate transfers, among others. Check out the information below to learn how to file your ITR-2 online or with the excel utility. Who needs to file ITR-2 for AY 2025-26 (FY 2024-25)? According to chartered accountant Abhishek Soni, co-founder, Tax2Win, here's the list of incomes that require you to file ITR-2: 'Income from salary or pension Income from house property(one or more) Income from other sources, including income from winning a lottery, income from owning and maintaining horse races, or income taxable at special rates. Persons who had investments in unlisted equity shares at any time during the entire financial year. An individual who is a director in a company. An individual who is a Resident(ROR/RNOR)or non-resident. Income earned from capital gains Income from foreign assets/ other foreign income. Agricultural income of more than Rs 5,000/- Incomes where clubbing provisions are applicable Individuals having a financial interest in assets located outside India, which includes any signing authority for accounts held outside India. One who desires to carry forward or bring forward loss under income from house property. Any tax has been deducted under Section 194N In cases where payment or deduction of tax has been deferred on ESOP.' Soni says: 'The total income can exceed Rs 50 lakh in ITR-2 unlike ITR-1.' Also read: ITR filing deadline: What is the last date for filing returns for taxpayers not requiring an audit? How to file ITR-2 using the excel utility? The ITR-2 form includes several schedules and in this article, we will walk you through a step-by-step guide, using capital gains as an example– covering both long and short term Soni's step-by-step guide to filing ITR-2 using the excel utility: Step 1: Download and Open the Excel Utility Visit the Income Tax e-Filing portal Navigate to 'Downloads' > ITR Forms > Select ITR-2 > Download Excel utility Step 2. Install and launch the ITR-2 excel utility Extract the ZIP file you downloaded. Open the utility and click Continue to proceed. Step 3. Filling Schedule 'Part-A General' You must fill in your basic details in this schedule Name, address, PAN, status, Name, Aadhaar, DOB, Mobile & Email Select your Residential status (choose Resident/Non-Resident accordingly) Select your filing type, Original or Revised. Select the ITR filing section, the date of filing the ITR, document identification number (if filed in response to a notice). If you are filing a return under section 139(1), you can choose to switch from the new to the old regime by selecting 'Yes' under 'Do you wish to exercise the option u/s 115BAC(6) of opting out of the new tax regime?' If your income is below the threshold required for mandatory ITR filing, but you are still filing ITR due to fulfilling any of the mandatory conditions listed in the seventh proviso to section 139(1), then select the reason accordingly. If you are a director in the company, fill in the required details like company name, type, PAN, DIN, and whether its shares are listed or unlisted. If you have held any unlisted equity shares in the FY, you must mention their details in the table given at the end. Step 4. Filling the Schedule 'Capital Gains' This tab is for reporting the sale of capital assets like shares, mutual funds, real estate, etc. Short-Term Capital Gains - Sale of Immovable Property Enter the details of the sale of immovable property. Fill in the date of acquisition and the date of sale of the property Full value of consideration, stamp duty value of the property. Enter the deductions like cost of acquisition, cost of improvement, and transfer expenses Enter the short-term capital gains on immovable property and the details of the transfer of immovable property. Sale of Equity Shares and Mutual Funds Enter the full value consideration, cost of acquisition, cost of improvement, and expenses on transfer Fill in the short-term capital gain on equity or equity-oriented mutual fund. Enter the details of any unutilized capital gains deposited in the Capital Gain Account Scheme (CGAS). Long-Term Capital Gains Fill in the details of the long-term capital gains Enter details like date of acquisition, date of sale, full value of consideration, and stamp duty value. Next, enter the cost of acquisition, cost of improvement, and transfer expenses. Fill in the amount of deductions under section 54, 54B, 54F, 54EC, if applicable. Note: While entering your capital gain details, make sure to classify your capital gains before and after 23rd July 2024 and mention accordingly. Enter the details of LTCG on the sale of unlisted bonds and unlisted debentures. Enter the details on the sale of listed securities or zero-coupon bonds. Step 5: Details of Set-off of Current Year Capital LossesEnter the details of the short-term and long-term capital losses set off against the capital gains in the table provided. Step 6: Final Submission Click on "Validate" on each sheet after filling Go to the "Part A – General" tab and click "Calculate Tax" Save the XML and upload the JSON via the Income Tax e-filing portal e-verify the ITR to complete the process How to file ITR-2 online via the e-filing ITR portal? Here's a step-by-step guide on how to file ITR-2 via the online e-filing ITR portal: Step 1: First login on the e-filing ITR portal using your credentials. Once logged in go to the e-file tab and hover over the 'Income Tax Returns' button and then click on 'File Income Tax Return' button. A new webpage will open and it will ask for some details – assessment year, mode of filing (online/offline). Click on 'continue' once done. Step 2: A new webpage will open and here you need to click on a button called 'Start New Filing'. When you click this button a new web page opens which asks you to 'Please select the status applicable to you to proceed further'. Click 'Continue'. In this example we used ITR-2. Step 3: Here's a list of do documents that will help you file the ITR-2 faster: Form 16 Form 16A Form-26AS Bank Statements Housing Loan Interest Certificates Receipts for Donation Made Rental Agreement, Rent Receipts, Investment premium payment receipts - LIC, ULIP Step 4: You must answer why you are filing ITR. Once the reason is selected, then click on 'Continue'. A new webpage opens and here you can check the pre-filed data. Once you have checked all the pre-filled data click on the 'Proceed to Verification' button. Do remember to e-verify your filed ITR within 30 days of filing it. The Income Tax Department said on the e-filing ITR portal: 'Income Tax return (ITR) is pre-filled based on the information available for pre-fill on e-Filing. There may be situations where such information may not be complete. The facility of pre-filling is only for providing assistance to the Taxpayers for filing their ITRs. Please verify the pre-filled data with your records and AIS/TIS before finalising and submitting the ITR. You have the option to make changes to pre-filled data.' ITR-2 Source: ITR e-filing portal N.R. Narayana Murthy Founder, Infosys Watch Now Harsh Mariwala Chairman & Founder, Marico Watch Now Adar Poonawalla CEO, Serum Institute of India Watch Now Ronnie Screwvala Chairperson & Co-founder, upGrad Watch Now Puneet Dalmia Managing Director, Dalmia Bharat group Watch Now Martin Schwenk Former President & CEO, Mercedes-Benz, Thailand Watch Now Nadir Godrej Managing Director, of Godrej Industries Watch Now Manu Jain Former- Global Vice President, Xiaomi Watch Now Nithin Kamath Founder, CEO, Zerodha Watch Now Anil Agarwal Executive Chairman, Vedanta Resources Watch Now Dr. Prathap C. Reddy Founder Chairman, Apollo Hospitals Watch Now Vikram Kirloskar Former Vice Chairman, Toyota Kirloskar Motor Watch Now Kiran Mazumdar Shaw Executive Chairperson, Biocon Limited Watch Now Shashi Kiran Shetty Chairman of Allcargo Logistics, ECU Worldwide and Gati Ltd Watch Now Samir K Modi Managing Director, Modi Enterprises Watch Now R Gopalakrishnan Former Director Tata Sons, Former Vice Chairman, HUL Watch Now Sanjiv Mehta Former Chairman / CEO, Hindustan Unilever Watch Now Dr Ajai Chowdhry Co-Founder, HCL, Chairman EPIC Foundation, Author, Just Aspire Watch Now Shiv Khera Author, Business Consultant, Motivational Speaker Watch Now Nakul Anand Executive Director, ITC Limited Watch Now RS Sodhi Former MD, Amul & President, Indian Dairy Association Watch Now Anil Rai Gupta Managing Director & Chairman, Havells Watch Now Zia Mody Co-Founder & Managing Partner, AZB & Partners Watch Now Arundhati Bhattacharya Chairperson & CEO, Salesforce India Watch Now
Economic Times
4 hours ago
- Economic Times
Hims & Hers Q2 revenue drop shakes stock—Hims crashes 11% after first-ever revenue decline, is the weight-loss drug hype finally fading?
Hims & Hers Health (NYSE: HIMS) saw its stock plunge over 11% after the company reported its Q2 2025 earnings, marking its first-ever sequential revenue decline. While revenue jumped 73% year-over-year to $544.8 million, it still fell short of Wall Street's expectations of $552 million, and notably dropped from $586 million in Q1. The miss has rattled investor confidence, especially as GLP-1 weight-loss drug sales, a key growth driver, showed signs of slowing amid regulatory pressure and legal setbacks. Synopsis Hims & Hers stock dropped a sharp 11% after the company missed Q2 2025 revenue estimates, raising concerns about its booming weight-loss drug business. While year-over-year sales jumped 73%, revenue fell sequentially for the first time, causing investor worry. The company brought in $544.8 million, short of forecasts, with much of it tied to its GLP-1 obesity drug offerings. Hims & Hers Health (NYSE: HIMS), the fast-growing telehealth company known for its personalized care plans and buzzy entry into the weight-loss market, saw its stock drop by over 11% after reporting second-quarter 2025 earnings. While revenue jumped 73% year-over-year, the company missed Wall Street expectations and posted its first-ever sequential revenue decline, raising questions about the future of its GLP-1 obesity drug business. ADVERTISEMENT Despite its rapid annual growth, Hims & Hers posted Q2 revenue of $544.8 million, missing the analyst estimate of $552 million. The real concern? Revenue dropped from $586 million in Q1, marking the first quarter-over-quarter decline since the company went public. The stock currently trades at $63.35, regaining some ground after hitting an intraday low of $54.82. Despite opening at $64.00, it remains volatile, with an intraday high of $65.54. ALSO READ: Bullish IPO debut: Peter Thiel-backed crypto giant targets $4.2B valuation—is the new crypto wave knocking on Wall Street's door? The market reacted sharply to the company's revenue miss—$544.8 million vs. $552 million expected—even though earnings per share beat expectations and subscriber numbers remained strong. Most of the company's revenue stemmed from its GLP-1-based obesity and diabetes treatments, a booming but increasingly scrutinized business segment. ALSO READ: Palantir stock soars after $1B Q2 earnings crush forecasts as AI demand fuels 110% YTD surge—now S&P 500's top performer ADVERTISEMENT With regulatory pressures, lawsuits from Novo Nordisk, and tighter FDA rules on compounded semaglutide, Hims faces headwinds in its fastest-growing segment. However, with a market cap of over $6.5 billion, a P/E ratio of 39.93, and forward-looking confidence via its Zava acquisition, the company is still betting big on growth in both the U.S. and Europe. Current Price : $63.35 : $63.35 Day Range : $54.82 – $65.54 : $54.82 – $65.54 Open : $64.00 : $64.00 Market Cap: $6.56 Billion P/E Ratio : 39.93 : 39.93 Volume: 35.5M Investors were caught off guard, as the slowdown came amid soaring demand for weight-loss drugs like semaglutide, a compound similar to the active ingredient in Wegovy and Ozempic. ADVERTISEMENT On the profit front, Hims reported an adjusted EPS of $0.19, beating the Street's expectation of $0.15. However, the revenue miss overshadowed this earnings win. Investors appeared more concerned about the underlying business momentum, particularly in the obesity treatment space, which has been a major driver of Hims' recent growth. ADVERTISEMENT Hims' biggest growth story in recent quarters has been its expansion into GLP-1 weight-loss treatments, which brought in around $190 million in Q2 alone. However, a few red flags have emerged: Regulatory uncertainty : With the FDA rolling back flexibility on compounded versions of semaglutide, questions are mounting about how long Hims can rely on this segment for revenue. : With the FDA rolling back flexibility on of semaglutide, questions are mounting about how long Hims can rely on this segment for revenue. Legal challenges : The company recently ended its supply relationship with Novo Nordisk , the maker of Wegovy, and is now facing lawsuits over how it marketed compounded alternatives. : The company recently ended its supply relationship with , the maker of Wegovy, and is now facing lawsuits over how it marketed compounded alternatives. Competitive pressure: Big players like Eli Lilly and Novo Nordisk are dominating the branded drug market, making it harder for telehealth companies offering generics to compete on pricing and trust. Despite the Q2 shortfall, Hims & Hers stuck to its full-year outlook. The company reaffirmed its 2025 guidance of $2.3 billion to $2.4 billion in revenue and $295 million to $335 million in adjusted EBITDA. ADVERTISEMENT A big reason? The Zava acquisition, a European telehealth platform, which is expected to contribute around $50 million in new revenue this year. This suggests Hims is betting heavily on international growth to offset some of its domestic uncertainty. One bright spot in the report was Hims' growing subscriber base. The company now serves over 2.4 million active subscribers, with nearly 70% enrolled in personalized treatment plans that span weight loss, hair care, sexual health, and mental wellness. CEO Andrew Dudum emphasized that the company is leaning deeper into its long-term strategy of personalized digital healthcare, aiming to build loyalty and customer lifetime value across multiple product categories. If you're following Hims & Hers stock or investing in telehealth companies focused on the obesity drug boom, here are four key things to monitor: Future of compounded GLP-1s: Regulatory and legal outcomes could limit Hims' ability to sell compounded semaglutide at scale. Profitability trends: Will margins hold up as more competition floods the market and Hims scales its personalized offerings? Subscriber growth and retention: Continued engagement in non-weight loss categories will be key to long-term stability. Zava integration: The success or failure of this acquisition could make or break Hims' international ambitions. Hims & Hers Health has come a long way as a digital-first wellness brand with a bold strategy around weight-loss drugs and personalized healthcare. But the 11% stock drop shows investor sentiment is shifting, especially as its flagship obesity business faces regulatory hurdles and supply uncertainty. For now, the company's strong year-over-year growth and firm 2025 guidance offer some reassurance. But with rising competition, tighter FDA rules, and legal pressure, Hims will need to prove that its success isn't just tied to a single product wave—but a durable, trusted digital care ecosystem. What caused Hims & Hers stock to fall 11% after Q2 earnings? The company missed revenue estimates and saw its first-ever sequential drop in sales. Is the Hims weight-loss drug business facing trouble in 2025? Yes, due to FDA scrutiny and legal issues around compounded semaglutide. (You can now subscribe to our Economic Times WhatsApp channel) (Catch all the US News, UK News, Canada News, International Breaking News Events, and Latest News Updates on The Economic Times.) Download The Economic Times News App to get Daily International News Updates. NEXT STORY
